Pharmaceutical Logistics Market Size, Share & Industry Analysis, By Transportation Mode (Airways, Railways, Roadways, and Waterways), By Service Type (Warehouse Services, Transportation, Inventory Management, and Administration & Supplies), By Logistics Type (Cold Chain Logistics and Non-Cold Chain Logistics), By Product Type (Biological, Biopharmaceutical, Raw Pharmaceutical Materials, Finished Pharmaceutical Goods, Medical Supplies, and Specialty Pharmaceutical), and Regional Forecast, 2025-2032

The global pharmaceutical logistics market size was valued at USD 66.39 billion in 2024. The market is projected to grow from USD 80.56 billion in 2025 to USD 140.13 billion by 2032, exhibiting a CAGR of 8.2% during the forecast period.

Pharmaceutical logistics involves the planning, execution, control of the movement, and storage of pharmaceutical products throughout the supply chain. It ensures the safe, efficient, and timely delivery of medicines, vaccines, and other healthcare products, maintaining proper temperature, and quality standards. This includes warehousing, inventory management, transportation, regulatory compliance, and cold chain logistics to guarantee product integrity from manufacturers to healthcare providers or end-users.

​The global pharmaceutical logistics market is experiencing significant growth, driven by the increasing demand for temperature-sensitive products such as biologics and vaccines. Advancements in technology, including RFID and IoT, are enhancing supply chain visibility and efficiency, thereby supporting the market's expansion over the forecast period.

​​Leading companies in the global pharmaceutical logistics industry include Deutsche Post DHL, Kuehne + Nagel, UPS, FedEx, McKesson, Cardinal Health, and CEVA Logistics, among others. These firms dominate through extensive global networks, advanced cold chain capabilities, and specialized services for temperature-sensitive pharmaceuticals. Recent strategic moves, such as UPS's acquisition of Andlauer Healthcare and CEVA's integration with Bolloré Logistics, underscore their commitment to expanding healthcare logistics and enhancing service offerings.

Request a Free sample to learn more about this report.

Market Dynamics

Market Drivers

Rising Demand for Biologics and Specialty Drugs Drives Market Demand

​Products such as vaccines, gene therapies, and monoclonal antibodies are highly sensitive to temperature, humidity, and handling conditions, requiring advanced cold chain logistics. As more biopharmaceutical innovations reach the market, logistics providers must invest in specialized storage facilities, refrigerated transportation, and real-time monitoring technologies to maintain product integrity. Additionally, specialty drugs such as vitamins, minerals, and supplements (VMS), often have shorter shelf lives and require faster delivery to hospitals, pharmacies, or patients. This trend pushes the development of tailored logistics solutions and robust global distribution networks. With increasing demand, logistics providers play a critical role in ensuring the safe and on-time delivery of these high-value therapies globally, fueling market growth over the forecast period.

Technological Advancements Propel Market Growth

Innovations such as Internet of Things (IoT) devices, blockchain, and Artificial Intelligence (AI) enable real-time monitoring and temperature monitoring of temperature-sensitive pharmaceuticals, reducing the risk of spoilage and ensuring compliance with regulatory standards. Automation and robotics in warehousing streamline inventory management, while data analytics optimize demand forecasting and route planning, minimizing costs. Additionally, cloud-based supply chain solutions and secured supply chains improve communication and collaboration across stakeholders, enhancing visibility and responsiveness. With technologies such as blockchain ensuring the traceability of pharmaceutical products, the industry can combat counterfeiting, ensuring product integrity and consumer safety. As the demand for advanced logistics solutions grows, technological advancements play a crucial role in driving market expansion.

In April 2025, SkyCell partnered with Microsoft to integrate its AI-powered supply chain solution into Microsoft Teams and Copilot. This collaboration aims to enhance real-time visibility and decision-making in the logistics of pharmaceuticals by leveraging advanced analytics and automation. The integration facilitates seamless communication and data sharing across the supply chain, improving efficiency and responsiveness in managing temperature-sensitive pharmaceutical shipments.

Market Restraints

Global Economic Factors to Restrain Market Growth

Different countries and regions enforce various regulations for pharmaceutical storage, transportation, labeling, and documentation, making international shipping highly challenging. Compliance with Good Distribution Practices (GDP) and other standards requires rigorous quality control, specialized equipment, and trained personnel, increasing operational costs and complexity. Frequent updates of regulations add uncertainty and result in delayed cross-border deliveries, impacting efficiency and profitability. Logistics providers must invest heavily in audits, certifications, and monitoring systems to ensure compliance, creating barriers for smaller firms. Additionally, any non-compliance can lead to penalties, product recalls, or damage to reputation, discouraging market entry and expansion. This regulatory fragmentation slows innovation and limits market growth potential, hampering market expansion.

Market Opportunities

Growth of E-commerce and Direct-to-Patient (DTP) Delivery Presents a Major Market Opportunity

As online drugstores and telemedicine gain traction, patients increasingly expect fast, convenient, and secure home delivery of medications. This trend accelerated since the COVID-19 pandemic, making reliable last-mile logistics a critical component of healthcare. Pharmaceutical logistics providers can capitalize by developing specialized services tailored to DTP, including temperature-controlled packaging, real-time tracking, and contactless delivery options. These services enhance patient experience, improve medication adherence, and expand market reach. Furthermore, e-commerce enables pharmaceutical companies to bypass traditional retail channels, creating demand for agile, technology-driven logistics networks. As this digital shift continues, logistics providers with innovative DTP solutions will gain a competitive advantage.

In October 2024, PCI Pharma Services received the Supply Chain Excellence Award USA for its PCI Bridge platform. This digital solution enhances supply chain visibility and reduces manual tasks such as forecasting, inventory management, and document sharing. Developed in collaboration with four prominent customers, PCI Bridge integrates real-time data across inventory, production, and distribution, supporting over 5,000 clinical and commercial products.

Market Challenges

High Cost of Cold Chain Infrastructure Poses a Significant Challenge

Temperature-sensitive drugs such as biologics, vaccines, and insulin require specialized types of equipment, such as refrigerated trucks, temperature-controlled warehouses, and real-time monitoring systems, to ensure product integrity. Building and maintaining this infrastructure demands substantial capital investment. Smaller logistics providers, especially in emerging markets, may struggle to compete with larger firms that can afford these costs. Additionally, rising energy costs and the need for continuous monitoring further add to operational expenses. As a result, these financial constraints limit the ability of smaller players to expand their services, slowing market growth and potentially increasing the overall cost of pharmaceuticals.

Pharmaceutical Logistics Market Trends

Outsourcing Logistics is a Leading Trend in the Pharmaceutical Industry

Outsourcing trends in the pharmaceutical industry are fueling the growth of the global pharmaceutical logistics industry by allowing establishments to focus on their core competencies, such as research and development. By outsourcing logistics to third-party providers (3PLs), pharmaceutical firms reduce capital expenditures for infrastructure, storage, and temperature-controlled transportation. These logistics providers offer specialized services such as cold chain management, regulatory compliance, and last-mile delivery, ensuring high-quality and efficient operations. Outsourcing also allows companies to scale operations in emerging markets without the need for substantial investment in local infrastructure. Additionally, third-party logistics providers leverage advanced technologies such as real-time tracking, AI, and IoT, improving visibility and efficiency, which further drives growth and competitiveness in the market.

For instance, in March 2025, Identiv partnered with Tag-N-Trac to launch a real-time cold chain tracking solution for the pharmaceutical industry. Combining Identiv's BLE smart labels with Tag-N-Trac's RELATIVITY SaaS platform, the integrated system enables continuous monitoring of temperature and humidity during transit. This collaboration aims to enhance compliance and ensure the integrity of temperature-sensitive pharmaceutical products.

Impact of Tariffs

Rising Production Expenses Hinder Market Demand as a Result of the Tariffs

President Donald Trump's proposed tariffs on pharmaceutical imports, including a 10% levy on Chinese goods and up to 25% on Canadian and Mexican products, are significantly impacting the global pharmaceutical market. The U.S. relies heavily on imports for Active Pharmaceutical Ingredients (APIs), with China supplying approximately 30% of these essential components. Tariffs on APIs are increasing production costs for generic drug manufacturers, who often operate on thin profit margins. This financial strain may lead some companies to exit the market, reducing competition and potentially causing shortages of critical medications. Additionally, the tariffs could disrupt the supply chain, leading to higher drug prices and exacerbating existing shortages of vital treatments such as cancer therapies and pain management medications. These developments raise concerns about patient access to affordable healthcare.

Segmentation Analysis

By Transportation Mode

Flexibility, Cost-Effectiveness, and Last-Mile Delivery Solutions Propel Roadways Adoption

The market segments are categorized into airways, railways, roadways, and waterways, by transportation mode.

The roadways segment dominated the market by holding the largest market share in 2024. Road transportation is crucial for the logistics of pharmaceuticals due to its tractability, cost-effectiveness, and ability to provide last-mile delivery solutions. Roadways are ideal for transporting bulk pharmaceuticals, especially for non-temperature-sensitive goods. They also play a vital role in regional single-source distribution channels and local deliveries, providing a more direct and accessible method of getting products to pharmacies, hospitals, and clinics. The growth of e-commerce and direct-to-patient services further drives demand for road-based logistics of pharmaceuticals.

In February 2025, Mitsubishi Logistics Corporation, Mitsubishi Corporation, and Yourstand Inc. announced a collaboration to introduce medium-sized electric trucks for pharmaceutical transportation. Starting in March, the "eCanter" trucks will operate from Mitsubishi Logistics' Misato base in Saitama, Japan. This initiative aims to achieve CO2-free logistics by integrating renewable energy, advanced charging infrastructure, and temperature-sensitive delivery systems. 

The airways segment is expected to gain traction with the fastest CAGR over the forecast period. Air transportation in the pharmaceutical supply chain is driven by the need for speed and efficiency, especially for time-sensitive or high-value products. Pharmaceuticals such as vaccines and specialized treatments often require rapid delivery to meet urgent market demands. Air transport offers faster transit times, reducing the risk of product spoilage or degradation. It is especially critical for cold chain logistics, ensuring that biologics or temperature-sensitive medicines reach their destination quickly while maintaining the required conditions.

By Service Type

Need for Fast, Secure, and Reliable Delivery of Medicines Boosts Transportation Demand

The market is characterized by service type into warehouse services, transportation, inventory management, and administration & supplies.

The transportation segment held the largest pharmaceutical logistics market share in 2024. The segment is also expected to grow at a rapid pace during the forecast period. Transportation services in the logistics of pharmaceuticals are driven by the need for fast, secure, and reliable delivery of medicines globally. Pharmaceutical transportation requires careful planning to comply with regulatory requirements and ensure product integrity during transit. The need for speed, especially for emergency deliveries (e.g., vaccines or critical drugs), as well as flexibility in handling temperature-sensitive goods, fuels growth in this segment. Advanced tracking and real-time monitoring systems also enhance service efficiency.

Inventory management held the second-largest market share in 2024. Effective inventory management is crucial for the logistics of pharmaceuticals in order to track large volumes of products and manage stock levels in real-time. This service ensures that pharmaceutical companies can avoid stockouts, reduce excess inventory, and improve order fulfillment accuracy. The increasing complication in global supply chains, along with stricter regulations, drives the demand for sophisticated inventory management systems that facilitate operations, ensuring that precise products are available at a convenient time and location.

In June 2024, DHL Supply Chain expanded its pharmaceutical logistics operations in France through a strategic partnership with Sanofi. This collaboration involves managing inventory control, warehousing, picking and packing, as well as order fulfillment at three major locations: Saint-Loubès, Croissy-Beaubourg, and Amilly Distribution. The partnership aims to enhance efficiency, resilience, and quality in Sanofi's logistics operations, leveraging DHL's expertise in the Life Sciences and healthcare sector.

By Logistics Type

Vast Volume of Non-temperature-sensitive Products Augments Non-cold Chain Logistics Segment Growth

The market is divided by logistics type into cold chain logistics and non-cold chain logistics.

Non-cold chain logistics segment dominated the market in 2024. This segment is primarily driven by the vast volume of non-temperature-sensitive products, such as finished pharmaceuticals and over-the-counter medicines. Despite lower storage and transport requirements, these products demand a strong global distribution network. Factors such as lower logistics costs, faster transit times, fast track assistance in healthcare, and the global rise in healthcare consumption contribute to the expansion of non-cold chain logistics.

Cold chain logistics are anticipated to witness the fastest growth over the forecast period. Growth of this segment is driven by the increasing demand for temperature-sensitive pharmaceuticals such as vaccines, biologics, and insulin. These products require strict temperature control throughout their journey from manufacturing to distribution. The rise of biologics and vaccines, particularly during the COVID-19 pandemic, expanded the need for advanced cold chain infrastructure. Logistics providers are investing in refrigerated storage, specialized transportation, and real-time monitoring systems to ensure the integrity of these temperature-sensitive products.

In March 2025, Cold Chain Technologies (CCT) and Tower Cold Chain unveiled a new temperature-controlled logistics solution at LogiPharma 2025 in Lyon. Their collaborative product, showcased at Booths 91A and 68, offers precise temperature control, universal compatibility with EU and U.S. pallets, and enhanced sustainability. Designed for the evolving pharmaceutical sector, it aims to set new benchmarks in efficiency and reliability. The launch event featured live demonstrations and expert-led sessions on sustainability and cooling advancements.

By Product Type

To know how our report can help streamline your business, Speak to Analyst

Need for Consistent Distribution to Global Healthcare Market Propels Finished Pharmaceutical Goods Demand

By product type, the market is divided into biological, biopharmaceutical, raw pharmaceutical materials, finished pharmaceutical goods, medical supplies, and specialty pharmaceuticals.

Finished pharmaceutical goods monopolized the market of pharmaceutical logistics in 2024. These goods include tablets, capsules, and syrups that are driven by the need for consistent distribution to global healthcare markets. Such products often require efficient transportation networks to ensure timely availability in pharmacies, hospitals, and clinics. The demand for these goods is heightened by rising healthcare access, aging populations, and chronic disease prevalence, all contributing to the growing need for efficient logistics of pharmaceuticals.

The increasing demand for products, including monoclonal antibodies and vaccines, drives the biopharmaceutical segment of pharmaceutical logistics. These products are sensitive to temperature and require specialized cold chain logistics. Biopharmaceuticals are increasingly used for treating complex diseases such as cancer, autoimmune disorders, and rare conditions. This boosts the demand for secure and efficient logistics solutions that ensure product integrity during storage and transport.

Pharmaceutical Logistics Market Regional Outlook

By geography, the market is categorized into North America, Europe, Asia Pacific, and rest of the world.

Europe

To get more information on the regional analysis of this market, Request a Free sample

Europe dominated the market in 2024. Europe's market is primarily driven by its well-established healthcare system and a growing focus on advanced biologics and specialty drugs. The region's strong regulatory framework, including the European Medicines Agency (EMA), ensures strict adherence to Good Distribution Practices (GDP). The expansion of the cold chain logistics segment is fueled by the increasing demand for temperature-sensitive vaccines and biologics. At the same time, the rising e-commerce trend and direct-to-patient delivery services further contribute to the market's growth. ​

In October 2024, Lonza announced the extension of its partnership with a major global biopharmaceutical partner to enhance the commercial-scale manufacture of Antibody-Drug Conjugates (ADCs). The agreement includes the construction of a bioconjugation suite at Lonza's Ibex Biopark in Visp, Switzerland, expected to be operational by 2027. This extension aims to meet the growing demand for ADC therapies and will create approximately 100 new jobs. ​

North America

North America held a sustainable market share in 2024. In this region, the market is driven by a robust healthcare infrastructure, increasing demand for biopharmaceuticals, and stringent regulatory requirements. The growing occurrence of chronic diseases, an aging population, and advancements in biotechnology contribute to the rising demand for specialized logistics services, such as cold chain transportation. Additionally, the COVID-19 pandemic accelerated demand for vaccines and temperature-sensitive drugs, further boosting the need for efficient logistics of pharmaceuticals in the region.

The U.S., holding the largest share of the North American market, is driven by the increasing demand for temperature-sensitive drugs, advancements in cold chain logistics, and the growing prevalence of chronic diseases. Regulatory requirements such as Good Distribution Practices (GDP) fuel the need for specialized storage and transportation solutions. Additionally, the rise of e-commerce and direct-to-patient deliveries, along with innovations in tracking technologies, is driving pharmaceutical logistics market growth in the U.S.

In March 2025, DHL Group announced the acquisition of CryoPDP, a U.S.-based specialty courier specializing in temperature-sensitive logistics for clinical trials, biopharma, and cell and gene therapies. The deal, valued in the three-digit million-euro range, aims to bolster DHL's Life Sciences and healthcare division, which generated over EUR 5 billion (USD 5.41 billion) in revenue in 2024. CryoPDP operates in 15 countries, managing over 600,000 shipments annually across more than 135 countries. The acquisition is part of DHL's strategy to expand its Pharma Specialized Network and enhance end-to-end solutions for the pharmaceutical sector. The transaction is dependent on regulatory approvals.

Asia Pacific

Asia Pacific held the second-largest market share in 2024. Asia Pacific is witnessing rapid growth in the pharmaceutical logistics market due to the increasing demand for affordable healthcare and rising healthcare investments, especially in China and India. The region's growing pharmaceutical manufacturing capabilities and increasing export demand also drive logistics requirements. The rise in chronic diseases, expanding access to healthcare, and the need for cold chain logistics due to biologics and vaccines contribute to the region's market expansion.

In June 2022, Nippon Express launched an ultra-low temperature-controlled logistics service for the pharmaceutical industry. This service handles goods requiring temperatures between -20°C and -85°C, catering to pharmaceutical products at research and development stages, including raw materials, intermediates, active pharmaceutical ingredients, and finished products. The initiative aligns with the company's "NX Group Business Plan 2023 - Dynamic Growth," emphasizing the pharmaceutical sector as a priority and enhancing quality control systems in accordance with Good Distribution Practices (GDP).​

Rest of the World

The rest of the world region, comprising South America and the Middle East & Africa, is expected to generate demand for the market at the fastest-growing CAGR during the forecast period. In the Rest of the World (RoW) region, pharmaceutical logistics growth is driven by improving healthcare infrastructure, especially in Latin America and the Middle East & Africa. Growing populations, rising prevalence of chronic diseases, and increasing healthcare access in emerging markets fuel demand for pharmaceutical products and logistics services. Additionally, the expansion of e-commerce and direct-to-patient services, combined with the need for cold chain logistics for vaccines and biologics, supports market growth in these regions.

In January 2024, Turkish Cargo launched its TK Pharma product line, introducing three service tiers, TK Pharma Standard, TK Pharma Extra, and TK Pharma Advanced, to enhance pharmaceutical logistics. These offerings provide tailored solutions for temperature-sensitive shipments, utilizing passive and active temperature-controlled containers, 24/7 monitoring, and dedicated storage. The services are supported by Turkish Cargo's IATA CEIV Pharma-certified facilities and advanced technologies at Istanbul Airport's SMARTIST center.

Competitive Landscape

Key Market Players

Adoption of Advanced Technologies, Acquisitions, Partnerships, and Mergers Drive Competitive Edge

The global pharmaceutical logistics market is highly competitive, characterized by a mix of large multinational logistics companies, specialized pharmaceutical logistics providers, and regional players. Major global logistics firms such as DHL, UPS, FedEx, and Kuehne + Nagel, among others, dominate the market, offering comprehensive services that include cold chain logistics, inventory management, and transportation solutions tailored to the pharmaceutical sector. These companies leverage advanced technologies such as real-time tracking, IoT, and AI to ensure efficiency and compliance. Additionally, specialized providers such as World Courier and C.H. Robinson focuses on the niche needs of pharmaceutical logistics, particularly for temperature-sensitive products. Competition is further strengthened by the growing demand for last-mile delivery solutions, especially with the rise of direct-to-patient services. Major players continuously undertake strategic initiatives such as mergers and acquisitions, seeking to toughen their market position and expand geographically.

In July 2024, CEVA Logistics, a subsidiary of the CMA CGM Group, integrated Bolloré Logistics into its operations. This strategic move enhances CEVA's capabilities in air and ocean freight, contract logistics, and project logistics. The integration aims to create a unified, product-driven organization, improving global service delivery and operational efficiency. ​

List of Key Pharmaceutical Logistics Companies Profiled

• Apollo Couriers (India)


• DHL (Germany)


• FarEye (India)


• Allcargo Logistics (India)


• Jones Elite Logistics (U.S.)


• Buske Logistics (U.S.)


• Logisber (Spain)


• DHL Supply Chain (Germany)


• Kuehne + Nagel (Switzerland)


• UPS Healthcare (U.S.)


• XPO Logistics (U.S.)


• C.H. Robinson (U.S.)


• DB Schenker (Germany)


• Kerry Logistics (Hong Kong)


• GEODIS (France)


• Kintetsu World Express (Japan)


• Triton International (U.S.)


• CEVA Logistics (Switzerland)


• Agility Logistics (Kuwait)


• DSV (Denmark)


• FedEx Supply Chain (U.S.)

Key Industry Developments

• ​In March 2025, the World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and supported by PwC UK, released the "Roadmap to Nature Positive: Foundations for the Pharmaceutical Sector." This publication marks a critical milestone in the pharmaceutical sector's efforts to understand its nature-related impacts and dependencies and identify key actions to drive nature-positive outcomes. The roadmap supports progress towards the global goal of halting and reversing nature loss by 2030, as outlined in the Global Biodiversity Framework (GBF). A system-wide, transformative approach is needed to progress towards this goal. For this reason, WBCSD, in partnership with GSK, brought together a working group of leading pharmaceutical companies, including AstraZeneca, Bayer, Novartis, Novo Nordisk, Reckitt, and Roche, to develop a roadmap toward nature-positive action for the pharmaceutical sector.


• In January 2025, Pharma Logistics, LLC and Rx Reverse Distributors, Inc. announced their merger, creating the largest pharmaceutical reverse distribution provider for retail pharmacies. The unified entity combines nearly 50 years of industry experience, offering enhanced customer service, advanced technology, and rapid turnaround times. The integration will centralize operations at Pharma Logistics’ state-of-the-art facility in Libertyville, Illinois, utilizing automated technology for efficient returns processing.


• In August 2024, LSPedia and Pharma Logistics announced a strategic partnership to enhance pharmaceutical reverse logistics and supply chain visibility. This collaboration integrates LSPedia's OneScan platform with Pharma Logistics' services, offering real-time tracking, streamlined compliance with DSCSA regulations, and improved recall management. This partnership aims to provide a comprehensive 360-degree view of the pharmaceutical supply chain, from manufacturing to end-of-life processing, benefiting health systems, pharmacies, and other stakeholders.


• In May 2024, USAID launched a USD 5 million initiative to bolster the regional production of active pharmaceutical ingredients (APIs) in Central Asia, focusing on Uzbekistan and Kazakhstan. The project, named "Diversifying Asia's Pharmaceutical Supply Chain," aims to enhance manufacturing capabilities, regulatory systems, and workforce development, thereby reducing reliance on imported medicines and improving access to quality-assured medical products in the region.


• In March 2024, Noramco launched the Noramco Group, integrating its subsidiaries Purisys and Halo Pharma to establish a comprehensive North American-based pharmaceutical supply chain services provider. This strategic move aims to address escalating drug shortages and quality concerns in the U.S. by enhancing domestic manufacturing capacity and improving supply chain reliability. The consolidation is expected to streamline processes, reduce logistics costs, and bolster regulatory compliance, thereby ensuring a stable supply of essential medications.

Investment Analysis and Opportunities

Rising Demand for Temperature-Sensitive Products Fuels Market Opportunity

The global pharmaceutical logistics market presents lucrative investment opportunities due to rising demand for temperature-sensitive products such as biologics, vaccines, and specialty drugs. A key area for investment is in cold chain logistics, as increasing demand for biologics and vaccines requires advanced temperature-controlled storage and transportation solutions. Technological innovations such as IoT, AI, and real-time tracking systems are also vital for enhancing supply chain visibility, efficiency, and compliance, creating opportunities in logistics technology. Additionally, strategic acquisitions are expanding the capabilities of major logistics providers, as observed with UPS's acquisition of Andlauer Healthcare Group. Investment in emerging markets, particularly in Asia-Pacific, offers significant growth potential due to increasing healthcare access and pharmaceutical production. These factors make the market attractive for long-term investment, with diverse avenues for growth.

Report Coverage

The global pharmaceutical logistics market research report analyzes the market in depth. It highlights crucial aspects such as prominent companies, market segmentation, competitive landscape, transportation mode, service type, product type, and logistics type. Besides this, the market research reports provide insights into the pharmaceutical logistics market trends and highlight significant industry developments. In addition to the aspects mentioned earlier, the report encompasses several factors contributing to the market growth over recent years.

To gain extensive insights into the market, Request for Customization

Report Scope & Segmentation